Resource Type

Journal Article 4

Year

2023 1

2022 1

2019 1

2012 1

Keywords

B7-H3 1

BCNU 1

Glioblastoma 1

Pharmacodynamics 1

Pharmacokinetics 1

Radioimmunotherapy 1

boron neutron capture therapy 1

cell(s) of origin 1

early diagnosis 1

glioblastoma 1

glioblastoma multiform 1

glioblastoma recurrence 1

glioma stem cells 1

hydrogel 1

nanoparticles 1

neural stem cells 1

oligodendrocyte precursor cells 1

subventricular zone 1

tumor resection 1

open ︾

Search scope:

排序: Display mode:

Long acting carmustine loaded natural extracellular matrix hydrogel for inhibition of glioblastoma recurrence

Frontiers of Chemical Science and Engineering 2022, Volume 16, Issue 4,   Pages 536-545 doi: 10.1007/s11705-021-2067-5

Abstract: Many scientific efforts have been made to penetrate the blood-brain barrier and target glioblastoma cellsMore attention should be given to local inhibition of recurrence after glioblastoma resection to meetbis(2-chloroethyl)-1-nitrosourea, BCNU) was the only local drug delivery system approved for clinical glioblastomaThe hydrogel was injected into the resection cavity of a glioblastoma tumor immediately after tumor removalof local drug implantation and delivery may provide a reliable method to inhibit the recurrence of glioblastoma

Keywords: BCNU     glioblastoma recurrence     tumor resection     nanoparticles     hydrogel    

A reignited debate over the cell(s) of origin for glioblastoma and its clinical implications

Xiaolin Fan, Yanzhen Xiong, Yuan Wang

Frontiers of Medicine 2019, Volume 13, Issue 5,   Pages 531-539 doi: 10.1007/s11684-019-0700-1

Abstract: Glioblastoma (GBM) is the most common and lethal primary neoplasm in the central nervous system.

Keywords: glioblastoma     cell(s) of origin     neural stem cells     oligodendrocyte precursor cells     subventricular zone    

Boron neutron capture therapy for glioblastoma of prospects and confused

Zhou Youxin,Sun Ting,Yang Weilian,Du Ziwei

Strategic Study of CAE 2012, Volume 14, Issue 8,   Pages 82-84

Abstract: radiotherapy of damage tumor cells, and α particle produced by which is effective to prevent glioblastomaThis is a review of BNCT prospect on glioblastoma multiform.

Keywords: boron neutron capture therapy     glioblastoma multiform     glioma stem cells    

Characterization of 131I-Labeled Humanized Anti-B7-H3 Antibodies for Radioimmunotherapy for Glioblastoma Article

Fengqing Fu, Meng Zheng, Shandong Zhao, Yan Wang, Minzhou Huang, Hanqing Chen, Ziyi Huang, Kaijie Zhang, Liyan Miao, Xueguang Zhang

Engineering 2023, Volume 30, Issue 11,   Pages 190-202 doi: 10.1016/j.eng.2023.05.011

Abstract:

B7 homolog 3 (B7-H3) has attracted much attention in glioblastoma (GBM) radioimmunotherapy (RIT) due

Keywords: B7-H3     Radioimmunotherapy     Glioblastoma     Pharmacokinetics     Pharmacodynamics    

Title Author Date Type Operation

Long acting carmustine loaded natural extracellular matrix hydrogel for inhibition of glioblastoma recurrence

Journal Article

A reignited debate over the cell(s) of origin for glioblastoma and its clinical implications

Xiaolin Fan, Yanzhen Xiong, Yuan Wang

Journal Article

Boron neutron capture therapy for glioblastoma of prospects and confused

Zhou Youxin,Sun Ting,Yang Weilian,Du Ziwei

Journal Article

Characterization of 131I-Labeled Humanized Anti-B7-H3 Antibodies for Radioimmunotherapy for Glioblastoma

Fengqing Fu, Meng Zheng, Shandong Zhao, Yan Wang, Minzhou Huang, Hanqing Chen, Ziyi Huang, Kaijie Zhang, Liyan Miao, Xueguang Zhang

Journal Article